Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
AssigneeAtrogi AB
InventorsTore Bengtsson, Hamza Bokhari, Marcelo Montenegro, Anastasia Kalinovich
Life of this patent
Estimating the term…
Abstract
There is herein provided a β2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, for use in the treatment or prophylaxis of a disease or disorder characterised by muscle wasting.
Claims20
A β2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, for use in the treatment or prophylaxis of a disease or disorder characterised by muscle wasting.
A method for the treatment or prophylaxis of a disease or disorder characterised by muscle wasting, comprising administration of a therapeutically effective amount of a β2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, to a patient in need thereof.
The use of a β2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prophylaxis of a disease or disorder characterised by muscle wasting.
A pharmaceutical formulation comprising a β2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, and optionally one or more pharmaceutically acceptable excipient, for use in the treatment or prophylaxis of a disease or disorder characterised by muscle wasting.
A pharmaceutical formulation comprising:
- (a) a β2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof;
- and
- (b) a therapeutic weight loss agent,
- and optionally one or more pharmaceutically acceptable excipient.
A combination or kit-of-parts comprising components:
- (A) a pharmaceutical formulation comprising a β2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, optionally in admixture with one or more pharmaceutically acceptable excipient, and
- (B) a pharmaceutical formulation comprising a therapeutic weight loss agent, optionally in admixture with one or more pharmaceutically acceptable excipient,
- wherein components (A) and (B) are each provided in a form that is suitable for administration in conjunction with the other.
Dependencies are inferred from the claim text.